![]() |
|
Spaces home Dr.Tolga ErgönençProfileFriendsBlogMore ![]() | ![]() |
Ziyaret ettiğiniz için teşekkürler!
|
Dr.Tolga ErgönençGüncel Anesteziyoloji ve Reanimasyon (Anesthesiology and Intensive Care)
Question of the Day Anesthesiology Question of the Day
SEAH Korucuk kampüsünde bugünBayramınızı en içten dileklerimle kutluyor,sağlık,mutluluk ve huzur dolu günler diliyorum. SEAH Korucuk kampüsü ameliyathanesinden bugüne ait kareler... TARK 2007 Poster SunularıBupivakain Ve Levobupivakainin Spinal Anestezi Uygulamalarında Etki Başlangıç Süreleri Ve Hemodinamik Etkilerinin Karşılaştırılması Uğur Uzun,Tolga Ergönenç , Jalan Şerbetçigil Ergönenç, Kadir İdin, Gülşen Bican, Ali Dirik, Gökhan Gedikli Karaciğer Kist Hidatik Cerrahisi Esnasında Gelişen Anaflaktik Şok Reaksiyonu Ece Altınay,Tolga Ergönenç,Engin Çelik,Hakan Demir SEAHSakarya Eğitim Ve Araştırma Hastanesi Korucuk Kampüsü Hastanesi ameliyathaneleri faaliyete başladı. Ameliyathane toplam 6 operasyon odası, 3 adet küçük müdahale odası, pre-op ve post-op üniteleri ve 8 yataklı PACU ile hizmet vermektedir. http://www.seah.gov.tr TARK 2007
Brugada syndrome1: Heart Rhythm. 2006 Sep;3(9):1074-8. Epub 2006 Jul 7. Genetic and biophysical basis for bupivacaine-induced ST segment elevation and VT/VF. Anesthesia unmasked Brugada syndrome. Vernooy K, Sicouri S, Dumaine R, Hong K, Oliva A, Burashnikov E, Timmermans C, Delhaas T, Crijns HJ, Antzelevitch C, Rodriguez LM, Brugada R. Department of Cardiology, Academic Hospital Maastricht, Maastricht, the Netherlands. BACKGROUND: Brugada syndrome is an inherited disease associated with sudden cardiac death. The electrocardiographic pattern associated with Brugada syndrome has been linked to the use of sodium channel blockers, including antiarrhythmics, trycyclics and anesthetics. OBJECTIVE: We report a case of bupivacaine-induced Brugada syndrome, in which we investigated the genetic, biophysical and path physiological mechanism involved. METHODS AND RESULTS: The patient developed a Brugada-like electrocardiographic pattern twice under the influence of bupivacaine. The first occurrence was accompanied by ventricular tachycardia (VT) which subsided after withdrawal of the anesthetic. The VT was also observed during co-administration of diltiazem and isosorbide-5-mononitrate, agents thought to facilitate ST segment elevation in the Brugada syndrome. Genetic analysis revealed a missense mutation in the alpha subunit of the cardiac sodium channel, SCN5A. Biophysical analysis by whole-cell patch-clamping revealed a reduction in sodium current as a result of the mutation. The study of bupivacaine in the wedge model revealed use-dependent changes in conduction, heterogeneous loss of the action potential dome in RV epicardium and phase 2 re-entry when the preparations were pretreated with low concentrations of the calcium channel blocker verapamil. CONCLUSION: Our findings indicate that bupivacaine may induce the electrocardiographic and arrhythmic manifestations of the Brugada syndrome in silent carriers of SCN5A mutations. The data have important implications in the management of patients who develop ST segment elevation when under the influence of anesthetics such as bupivacaine. PMID: 16945804 [PubMed - in process] Makale
Control of shivering during regional anaesthesia: prophylactic ketamine and granisetron. Sagir O, Gulhas N, Toprak H, Yucel A, Begec Z, Ersoy O. Inonu University, School of Medicine, Malatya, Turkey. Background: The aim of the present study was to compare placebo, ketamine, granisetron and a combination of ketamine and granisetron in the prevention of shivering caused by regional anaesthesia. Methods: In this prospective, randomized, double-blind study, 160 ASA I and II patients undergoing urological surgery were included. Subarachnoid anaesthesia was performed in all patients with bupivacaine 15 mg. The patients were randomly allocated to receive saline (group P, n= 40), ketamine 0.5 mg (group K, n= 40), granisetron 3 mg (group G, n= 40) or ketamine 0.25 mg + granisetron 1.5 mg (group KG, n= 40). Shivering was graded as 0 = no shivering, 1 = piloerection or peripheral vasoconstriction but no visible shivering, 2 = muscular activity in only one muscle group, 3 = muscular activity in more than one muscle group but not generalized, and 4 = shivering involving the whole body. If 15 min after spinal anaesthesia and concomitant administration of a prophylactic dose of one of the study drugs, the patients shivered according to at least grade 3, the prophylaxis was regarded as ineffective and intravenous (i.v.) pethidine 25 mg was administered. Results: After 15 min, the number of patients with observed shivering was 22 in group P, 6 in group G, 7 in group GK and 0 in group K. The difference between group K and all the other groups was statistically significant (P < 0.0001). The number of patients with a shivering score of 3 was statistically significantly higher in group P compared with the other groups. Conclusion: The prophylactic use of 0.5 mg/kg i.v. ketamine was effective in preventing shivering developed during regional anaesthesia. PMID: 17229229 [PubMed - in process] MakalePost-dural puncture headache: pathogenesis, prevention and treatment (BJA, 2003, Vol. 91, No. 5 718-729) AlzheimerReported February 7, 2007
Anesthesia and Alzheimer's LinkORLANDO, Fla. -- A common anesthetic may induce biomarkers of Alzheimer's disease. Isoflurane (Forane), a general anesthetic inhalant, may cause cell death and generation of an Alzheimer's- associated protein, recent research reveals. General anesthesia may increase risk for Alzheimer's disease. One biomarker of Alzheimer's disease is the presence of plaques in the brain. Amyloid-beta protein (A-beta) is toxic to brain cells and is a key component in these plaques. Apoptosis, or cell death, is another indicator of cognitive decline. Previous research revealed application of isoflurane to neural cells in a lab led to apoptosis and the generation of A-beta. "Isoflurane can be one of the most commonly used anesthetics in operation. We use it every day," lead author Zhongcong Xie, M.D., Ph.D., of the MassGeneral Institute for Neurodegenerative Disease in Charlestown, Mass., told Ivanhoe. Researchers at Massachusetts General Hospital in Boston applied isoflurane to cultured neural cells in a series of experiments. They reported activation of caspase, an enzyme that contributes to apoptosis. When researchers applied isoflurane to neural cells that express amyloid precursor protein (APP), which aids the formation of A-beta, isoflurane raised levels of A-beta-releasing enzymes. Study results indicate isoflurane promotes apoptosis and the production of A-beta through specific molecular pathways. Isoflurane may also initiate a process by which A-beta generation and apoptosis interact and magnify one another. Researchers only used cultured cells in their study. Dr. Xie said while these kinds of lab studies can give scientists a preliminary understanding of how medications affect disease, it's still too early to know if the same reactions would be seen in humans. "This is alarming, but it's still premature to come to a conclusion," said Dr. Xie. "We need to work hard to have more data to support our hypothesis that isoflurane is toxic and facilitates dementia, or cognitive dysfunction, in humans." SOURCE: Ivanhoe interview with Zhongcong Xie, M.D., Ph.D.; The Journal of Neuroscience, 2007;27:1247- 1254 MakaleDo patients profit from physostigmine in recovery from desflurane anaesthesia?K. D. Röhm1, J. Riechmann22 , J. Boldt1 , T. Schöllhorn1 , S. N. Piper1 1Department of Anaesthesiology and Intensive Care Medicine, Klinikum Ludwigshafen, Ludwigshafen and 2Department of Anaesthesiology, University Hospital of Johannes Gutenberg-University Mainz, Mainz, Germany Kerstin D. Röhm Department of Anaesthesiology and Intensive Care Medicine Klinikum Ludwigshafen Bremserstrasse 79 D-67063 Ludwigshafen Germany e-mail: k.d.roehm@web.de AbstractBackground: Physostigmine is the drug of choice in the central anticholinergic syndrome, but has also been used in post-operative mental derangement secondary to sedatives and volatile anaesthetics. The aim of this double-blind, randomized, prospective study was to determine whether physostigmine alters recovery after desflurane anaesthesia. Methods: One hundred patients undergoing urologic or surgical procedures were enrolled to receive either NaCl 0.9% (n = 50) or 2 mg of physostigmine (n = 50) at the end of general anaesthesia with propofol, fentanyl, cisatracurium and desflurane. Times to extubation, stating name, birthday and place of residence, and obeying commands such as eye opening and hand squeezing were noted. Haemodynamics, Aldrete and pain scores, the analgesic requirements, and any adverse side-effects were documented until the 1st post-operative day. Results: Demographic, peri-operative data including duration of anaesthesia, surgery and postanaesthetic care unit (PACU) stay, and consumption of anaesthetics were comparable in both groups. No significant difference between the groups was found for extubation time or other emergence parameters. Patients undergoing anaesthesia >150 min showed after receiving physostigmine significantly (P < 0.05) faster spontaneous breathing (2.6 ± 3.1 vs. placebo 5.0 ± 4.2 min) and extubation time (6.2 ± 3.7 vs. placebo 8.8 ± 5.0 min). Women showed significantly shorter extubation times (5.5 ± 3.4 min) and eye opening (5.5 ± 2.6 min) with physostigmine than placebo (7.7 ± 4.5 and 7.8 ± 4.0 min). The incidence of post-operative nausea and vomiting (PONV) was significantly higher after physostigmine than placebo, whereas shivering occurred more often after placebo. Conclusion: Physostigmine does not alter desflurane-based anaesthesia compared with placebo. An option is to use physostigmine in patients with a duration of anaesthesia >150 min who profit in earlier return to spontaneous breathing and shorter extubation time. MakaleOR efficiency boosted by pre-op clinic visitsAnethesiology 2006; 105: 1254–1259![]() Pre-operative consultations can significantly increase efficiency in the operating room (OR) by allowing medical issues to be identified and resolved before surgery, according to the results of a retrospective study. This is the view of surgeons at Brigham and Women’s Hospital in Boston, Massachusetts, USA, where all patients undergoing elective procedures are evaluated in a pre-operative clinic. To assess the economic impact of these visits, Darin Correll and colleagues retrospectively studied the charts of 5083 patients seen at the Hospital over a 3-month period. Medical issues requiring further action were identified in 647 patients, Correll et al report in the journal Anesthesiology. The vast majority (87%) of issues were cardiac in origin, followed by pulmonary, anesthetic, and hematologic problems. Many of the issues related to pre-existing problems and simply required the retrieval of information from other centers. However, in 115 cases a new medical problem was identified at the pre-operative visit. The most common findings were electrocardiographic abnormalities or new cardiac symptoms that required an additional test or consultation. Importantly, around one in 10 patients in whom new medical issues were identified had their operation delayed or canceled, a finding with implications for costs and resource use, say the authors. “It is difficult to calculate the financial impact if the missing information results in a delay rather than a cancellation,” they write. “However, should case delay result in the overall lengthening of the operating room day, resulting in increased overtime as well as shift differential payments, the variable costs of running the operating room would increase.” Correll et al conclude that pre-operative clinic visits streamline assessment, allow implementation of protocols that may improve outcomes, and increase OR efficiency. MakaleA New Video Laryngoscope - An Aid in Intubation and Teaching (Department of Anesthesia, Cedars-Sinai Medical Center, Los Angeles)
|
|
||||||||||||||||||||||||||||||||||||||
|
|